Quantification of CMV viraemia in a case of transfusion-related graft- versus-host disease associated with purine analogue treatment

British Journal of Haematology

Volumn 99, Issue 1, 1997, Pages 162-164

  Deane, Miriam ^a,c   Gor, Dehila ^a   Macmahon, M Eithne ^a,b   Emery, Vince ^a   Griffith, Paul D ^a   Cummins, Michelle ^a   Prentice, H Grant ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c NORFOLK AND NORWICH HOSPITAL   (United Kingdom)

Author keywords

CMV; Fludarabine; Quantitative PCR assay; Transfusion associated GVHD

Indexed keywords

ACICLOVIR; CYTARABINE; DAUNORUBICIN; FLUDARABINE; FOSCARNET; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; IMMUNOGLOBULIN; LYMPHOCYTE ANTIBODY; PURINE DERIVATIVE; TIOGUANINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE DEPLETION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; VIREMIA;

EID: 0030776513     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.3443158.x     Document Type: Article

References (11)

1. Darlington, J., Super, M., Patel, K., Grundy, J.E., Griffiths, P.D. & Emery, V.C. (1991) Use of the polymerase chain reaction to analyse sequence variation within a major neutralising epitope of glycoprotein B (gp58) in clinical isolates of human cytomegalovirus. Journal of General Virology 72, 1984-1989.
2. Estey, E., Thall, P., Andreeff, M., Beran, M., Kantarjian, M., O'Brien, S., Escudier, S., Robertson, L.E., Koller, C., Kornblau, S., Pierce, S., Freireich, E.J., Deisseroth, A. & Keating, M. (1994) Use of granulocyte colony-stimulating factor before, during and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukaemia or myelodysplastic syndromes. Journal of Clinical Oncology, 12, 671-678.
3. Fox, J.C., Griffiths, P.D. & Emery, V.C. (1992) Quantification of human cytomegalovirus DNA using the polymerase chain reaction. Journal of General Virology, 2, 2405.
4. Greenbaum, B.H. (1991) Transfusion-associated graft-versus-host disease: historical perspectives, incidence and current use of irradiated blood products. Journal of Clinical Oncology, 9, 1889-1902.
5. Khouri, I.F., Keating, M.J., Vriesendorp, H.M., Reading, C.L., Przepiorka, D., Huh, Y.O., Andersson, B.S., van Biesen, K.W., Mehra, R.C. & Giralt, S.A. (1994) Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results. Journal of Clinical Oncology, 12, 748-758.
6. Li, C.R., Greenberg, P.D., Gilbert, M.J., Goodrich, J.M. & Riddell, S.R. (1994) Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of gancyclovir prophylaxis. Blood, 83, 1971-1979.
7. Maung, Z.T., Wood, A.C., Jackson, G.H., Turner, G.E., Appleton, A.L. & Hamilton, P.J. (1994) Transfusion-associated graft-versus-host disease in fludarabine treated B-chronic lymphocytic leukaemia. British Journal of Haematology, 88, 649-652.
8. Schilling, P.J. & Vadhan-Raj, S. (1990) Concurrent cytomegalovirus and pneumocystis pneumonia after fludarabine therapy for chronic lymphocytic leukemia. (Letter). New England Journal of Medicine, 323, 833-834.
9. Shivdasani, R.A., Haluska, F.G., Dock, N.L., Dover, J.S., Kineke, E.J. & Anderson, K.C. (1993) Graft-versus-host disease associated with transfusion of blood from unrelated HLA-homozygous donors. New England Journal of Medicine, 328, 766-770.
10. Wijermans, P.W., Gerrits, W.B. & Haak, H.L. (1993) Severe immunodeficiency in patients treated with fludarabine monophosphate. European Journal of Haematology, 50, 292-296.
11. Williamson, L.M., Wimperis, J.Z., Wood, M.E. & Woodcock, B. (1996) Fludarabine treatment and transfusion associated graft versus host disease. (Letter). Lancet, 348, 472-473.